公司资料
Lipocine Inc. 股价、新闻与催化剂
- 股票代码:
- LPCN
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
2.05 USD (-2.84%)
收盘价
最后更新: 2026年8月17日
18.5M USD
市值
股价为何变动
As of Aug 17, 2026, LPCN closed down 2.84% at $2.05. No new same-company headline was identified in the current news window.
公司概览
Oral Drug-Delivery Platform
Lipocine develops oral formulations intended to improve the delivery of therapeutics that are otherwise difficult to administer effectively by mouth.
LPCN 1154
LPCN 1154 is an oral formulation of brexanolone developed for postpartum depression. A Phase 3 study did not meet its primary endpoint, leaving the program's future development path uncertain.
Product-Focused Development Model
The company applies its formulation technology to established active pharmaceutical ingredients, seeking differentiated dosing, convenience or pharmacokinetic profiles in endocrine and neuropsychiatric indications.
未来催化剂
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。